Alla / NASDAQ / IRulya Therapeutics

IRulya Therapeutics

IRulya Therapeutics

Investera provisionsfritt

Köp och sälj delar av aktier för så lite som 1 €

Info och statistik

Dagens utbud
1 d−100,00 %
3 m−100,00 %
1 v−100,00 %
6 m−100,00 %
1 m−100,00 %
1 å−100,00 %
SYMBOL
IRLA
MARKNAD
NASDAQ
ISIN
US22053A3059

Datum

Stängnings

Förändring

Förändring (%)

Öppnings

Högt

Lågt

33,083,3310,07 %29,7533,0827,39
32,83−2,87−8,74 %35,7035,7031,34
34,68−5,31−15,31 %39,9940,9834,01
40,275,2913,14 %34,9840,6234,79
34,453,449,99 %31,0134,5031,01
32,03−0,17−0,53 %32,2034,3231,62
33,234,2412,76 %28,9933,7128,99
30,003,2810,93 %26,7230,0026,72
27,87−0,64−2,3 %28,5130,3525,50
32,404,2313,06 %28,1732,6026,92
31,731,233,88 %30,5037,0030,20
29,362,277,73 %27,0929,8026,84
26,72−0,02−0,07 %26,7427,9526,72
26,81−0,87−3,25 %27,6828,1526,81
28,10−0,89−3,17 %28,9929,7628,01
29,20−1,00−3,42 %30,2030,7029,20
30,68−1,31−4,27 %31,9931,9929,20
31,01−0,96−3,1 %31,9732,5930,62
31,171,374,4 %29,8032,0029,63
29,00−1,00−3,45 %30,0030,9526,90
31,000,601,94 %30,4031,0029,98
30,00−0,81−2,7 %30,8130,8129,65
30,15−0,86−2,85 %31,0131,0129,47
31,35−1,44−4,59 %32,7932,7930,50
31,001,825,87 %29,1831,0029,10
29,482,277,7 %27,2129,8927,21
27,01−0,16−0,59 %27,1727,5626,62
27,17−0,22−0,81 %27,3928,4025,77
28,840,270,94 %28,5729,9027,15
28,59−0,69−2,41 %29,2829,2826,99
29,550,672,27 %28,8830,0028,88
28,96−1,04−3,59 %30,0030,0028,31
30,310,842,77 %29,4730,3129,01
29,50−2,38−8,07 %31,8831,8829,01
31,320,792,52 %30,5333,4030,00
30,55−2,41−7,89 %32,9632,9630,55
32,15−0,77−2,4 %32,9233,0532,04
32,11−0,92−2,87 %33,0333,4832,11
32,57−1,47−4,51 %34,0434,0432,17
33,750,842,49 %32,9135,3431,84
32,500,511,57 %31,9932,7329,95
31,31−0,59−1,88 %31,9032,0131,31
30,93−1,47−4,75 %32,4033,6930,93
32,50−0,50−1,54 %33,0033,5032,50
33,930,782,3 %33,1534,0832,57
32,11−2,46−7,66 %34,5734,9532,11
34,571,684,86 %32,8934,9031,25
32,91−0,09−0,27 %33,0034,8432,66
34,12−0,83−2,43 %34,9535,2333,08
34,042,266,64 %31,7835,0431,78
32,411,073,3 %31,3433,7330,95
31,26−1,66−5,31 %32,9232,9230,03
32,731,233,76 %31,5033,0930,50
30,650,652,12 %30,0031,4730,00
30,200,280,93 %29,9230,6529,37
29,540,371,25 %29,1730,3228,55
28,881,725,96 %27,1629,9927,16
27,411,766,42 %25,6527,4824,80
24,961,024,09 %23,9426,6123,50
23,39−0,08−0,34 %23,4724,5921,90
23,031,225,3 %21,8123,6521,76
22,002,4911,32 %19,5122,4018,42
19,371,909,81 %17,4719,3717,44
17,850,201,12 %17,6518,2817,64
17,85−0,43−2,41 %18,2818,2817,51
18,280,040,22 %18,2418,6317,82
18,54−0,10−0,54 %18,6418,8817,55
18,78−0,21−1,12 %18,9919,1318,54
18,82−0,06−0,32 %18,8819,3818,29
18,880,201,06 %18,6818,8817,98
18,67−0,15−0,8 %18,8220,6518,47
18,58−0,51−2,74 %19,0919,6317,32
19,292,5913,43 %16,7019,9816,24
17,25−0,54−3,13 %17,7918,2017,21
17,540,100,57 %17,4417,7017,23
17,490,010,06 %17,4817,7216,92
17,25−0,49−2,84 %17,7417,7416,90
17,500,623,54 %16,8817,8416,39
16,98−0,23−1,35 %17,2117,3516,82
17,230,925,34 %16,3117,2416,07
16,75−1,25−7,46 %18,0018,0015,10
18,19−0,33−1,81 %18,5219,2416,84
18,41−0,19−1,03 %18,6019,4017,68
18,87−0,07−0,37 %18,9420,2018,56
19,520,492,51 %19,0319,7018,64
19,03−1,17−6,15 %20,2020,2018,95
19,360,964,96 %18,4020,0018,00
18,550,150,81 %18,4018,9318,23
18,900,904,76 %18,0019,9617,85
18,060,100,55 %17,9618,8517,69
18,01−0,39−2,17 %18,4018,4618,00
18,620,010,05 %18,6119,6018,40
18,67−0,13−0,7 %18,8019,9118,33
18,940,542,85 %18,4019,2217,80
18,20−1,40−7,69 %19,6020,3018,20
19,40−0,40−2,06 %19,8020,2019,10
20,00−0,40−2 %20,4020,6020,00
20,20−1,40−6,93 %21,6021,7020,20
22,001,607,27 %20,4023,0020,20
20,60−0,80−3,88 %21,4021,4020,00
21,00−1,00−4,76 %22,0022,2021,00
22,20−0,80−3,6 %23,0023,6022,20
23,00−0,60−2,61 %23,6024,4023,00
23,400,401,71 %23,0023,8022,20
23,00−1,00−4,35 %24,0025,2023,00
24,002,6010,83 %21,4025,6021,20
22,001,205,45 %20,8022,6020,80
21,40−0,40−1,87 %21,8021,8020,20
21,600,200,93 %21,4022,0020,20
21,400,602,8 %20,8022,2019,20
19,90−6,90−34,67 %26,8027,0018,00
23,00−0,60−2,61 %23,6023,6022,80
23,60−0,40−1,69 %24,0024,4023,60
24,400,000 %24,4025,4024,00
25,200,803,17 %24,4025,2024,00
24,80−0,40−1,61 %25,2025,2024,40
25,600,000 %25,6026,4024,00
26,001,405,38 %24,6026,2024,20
24,40−0,40−1,64 %24,8025,8024,40
24,60−0,20−0,81 %24,8025,0023,60
24,40−1,00−4,1 %25,4025,8024,20
26,601,003,76 %25,6026,8025,20
26,202,208,4 %24,0026,4024,00
24,60−0,20−0,81 %24,8025,2024,00
24,60−0,40−1,63 %25,0025,4023,40
25,80−0,60−2,33 %26,4026,8025,00
27,20−0,20−0,74 %27,4027,4026,20
27,20−0,20−0,74 %27,4030,4026,00
27,400,401,46 %27,0028,6026,80
26,801,405,22 %25,4028,4025,20
25,400,602,36 %24,8028,2024,60
27,400,000 %27,4028,6025,60
26,803,4012,69 %23,4028,0023,40
24,601,004,07 %23,6025,0022,40
25,000,000 %25,0026,4024,00
28,202,408,51 %25,8029,0022,80
27,264,6016,87 %22,6630,7222,66
24,74−0,26−1,05 %25,0031,7823,22
36,62−30,16−82,36 %66,7874,9033,90
32,6013,8842,58 %18,7237,7418,08
17,50−2,10−12 %19,6019,6217,50
19,800,000 %19,8020,0018,60
20,460,160,78 %20,3021,4619,60
20,280,281,38 %20,0020,5018,64
20,26−2,40−11,85 %22,6622,6618,44
17,52−1,10−6,28 %18,6219,6016,96
18,82−0,06−0,32 %18,8820,5418,10
20,401,949,51 %18,4622,2417,50
18,620,623,33 %18,0018,7817,60
20,323,2215,85 %17,1020,5616,10
16,00−1,64−10,25 %17,6418,9616,00
17,540,603,42 %16,9417,9416,10
19,40−0,40−2,06 %19,8020,3818,92
19,80−0,40−2,02 %20,2020,3219,24
20,800,281,35 %20,5220,8020,02
21,300,100,47 %21,2021,3020,18
21,30−0,42−1,97 %21,7221,8019,92
21,720,421,93 %21,3024,5821,06
20,80−0,20−0,96 %21,0021,0819,16
21,301,667,79 %19,6421,7019,06
20,460,180,88 %20,2822,0019,60
21,88−2,44−11,15 %24,3226,4820,30
20,801,748,37 %19,0621,9617,88
19,041,286,72 %17,7619,4217,60
19,76−2,40−12,15 %22,1622,1819,76
25,14−1,72−6,84 %26,8626,8823,76
27,700,461,66 %27,2428,2826,68
26,40−4,84−18,33 %31,2431,6026,16
27,84−0,10−0,36 %27,9431,1027,08
27,40−2,52−9,2 %29,9230,7626,98
30,02−0,32−1,07 %30,3433,3030,00
32,440,401,23 %32,0433,9232,00
35,603,309,27 %32,3047,3231,86
37,001,002,7 %36,0037,0031,60
40,00−16,02−40,05 %56,0258,9838,40
45,10−32,66−72,42 %77,7683,0044,24
122,00−20,70−16,97 %142,70195,12105,02
105,5448,8646,3 %56,68129,4849,18
26,00−2,00−7,69 %28,0029,2625,02
27,82−1,38−4,96 %29,2029,2026,68
29,22−2,56−8,76 %31,7831,7828,58
31,782,668,37 %29,1232,3028,00
29,08−7,52−25,86 %36,6036,7628,88
36,002,747,61 %33,2636,5831,40
34,00−16,00−47,06 %50,0051,5032,20
54,02−573,98−1 062,53 %628,00630,0046,00
636,00−32,00−5,03 %668,00670,00630,00
662,0064,009,67 %598,00682,00598,00
596,00−18,00−3,02 %614,00630,00586,00
616,00−28,00−4,55 %644,00644,00600,00
648,008,001,23 %640,00672,00622,00
650,00−30,00−4,62 %680,00688,00626,00
684,00−16,00−2,34 %700,00744,00660,00
710,00120,0016,9 %590,00732,00590,00
576,00−28,00−4,86 %604,00616,00570,00
602,006,001 %596,00628,00586,00
602,00−8,00−1,33 %610,00630,00562,00
590,0056,009,49 %534,00606,00512,00
538,00−12,00−2,23 %550,00562,00526,00
536,00−52,00−9,7 %588,00588,00534,00
582,00−2,00−0,34 %584,00606,00574,00
556,00−16,00−2,88 %572,00588,00544,00
572,00−46,00−8,04 %618,00618,00570,00
600,00−68,00−11,33 %668,00674,00590,00
670,0018,002,69 %652,00670,00640,00
652,00−24,00−3,68 %676,00678,00636,00
680,00−32,00−4,71 %712,00712,00676,00
712,00−20,00−2,81 %732,00736,00674,00
732,000,000 %732,00750,00720,00
734,008,001,09 %726,00752,00722,00
730,002,000,27 %728,00758,00716,00
714,0020,002,8 %694,00732,00686,00
696,00−56,00−8,05 %752,00790,00688,00
744,00−16,00−2,15 %760,00798,00712,00
740,00−28,00−3,78 %768,00800,00740,00
754,00−90,00−11,94 %844,00850,00746,00
844,00−38,00−4,5 %882,00908,00840,00
880,0094,0010,68 %786,00896,00780,00
798,0022,002,76 %776,00814,00748,00
772,00−8,00−1,04 %780,00800,00760,00
780,00−14,00−1,79 %794,00806,00718,00
802,0066,008,23 %736,00860,00730,00
720,0014,001,94 %706,00742,00704,00
704,0028,003,98 %676,00740,00660,00
676,0044,006,51 %632,00686,00602,00
634,00−86,00−13,56 %720,00730,00584,00
730,0038,005,21 %692,00744,00656,00
690,00136,0019,71 %554,00716,00552,00
534,0030,005,62 %504,00566,00500,00
500,0070,0014 %430,00540,00430,00
428,0022,005,14 %406,00430,00390,00
408,0018,004,41 %390,00418,00384,00
386,000,000 %386,00390,00368,00
382,0028,007,33 %354,00390,00340,00
360,0018,005 %342,00376,00336,00
336,0010,002,98 %326,00350,00322,00
336,00−6,00−1,79 %342,00348,00326,00
342,00−12,00−3,51 %354,00366,00322,00
358,0042,0011,73 %316,00366,00288,00
320,000,000 %320,00332,00316,00
312,00−2,00−0,64 %314,00316,00304,00
318,00−4,00−1,26 %322,00324,00312,00
316,00−4,00−1,27 %320,00326,00310,00
320,008,002,5 %312,00324,00310,00
326,00−6,00−1,84 %332,00334,00314,00
330,002,000,61 %328,00336,00318,00
330,00−2,00−0,61 %332,00338,00326,00
336,00−6,00−1,79 %342,00346,00332,00
346,00−4,00−1,16 %350,00358,00338,00
358,00−4,00−1,12 %362,00374,00350,00
352,002,000,57 %350,00366,00350,00
356,00−6,00−1,69 %362,00368,00350,00
364,002,000,55 %362,00366,00352,00
364,00−14,00−3,85 %378,00390,00354,00
370,002,000,54 %368,00378,00358,00
372,00−18,00−4,84 %390,00390,00366,00
386,00−4,00−1,04 %390,00408,00380,00
396,006,001,52 %390,00400,00382,00
388,00−10,00−2,58 %398,00402,00382,00
392,0020,005,1 %372,00394,00364,00
374,00−46,00−12,3 %420,00430,00370,00
408,0030,007,35 %378,00418,00372,00
384,0034,008,85 %350,00390,00336,00
356,00−32,00−8,99 %388,00410,00328,00
390,0050,0012,82 %340,00392,00334,00
330,00−2,00−0,61 %332,00336,00326,00
328,004,001,22 %324,00332,00324,00
324,00−2,00−0,62 %326,00334,00322,00
326,006,001,84 %320,00328,00320,00
322,000,000 %322,00330,00318,00
322,00−4,00−1,24 %326,00334,00318,00
326,006,001,84 %320,00332,00320,00
324,004,001,23 %320,00328,00320,00
322,006,001,86 %316,00326,00316,00
324,008,002,47 %316,00328,00314,00
320,000,000 %320,00326,00316,00
322,00−10,00−3,11 %332,00332,00318,00
322,00−4,00−1,24 %326,00334,00322,00
324,002,000,62 %322,00330,00320,00
320,000,000 %320,00324,00316,00
320,004,001,25 %316,00324,00316,00
316,00−4,00−1,27 %320,00334,00314,00
322,000,000 %322,00332,00322,00
322,0010,003,11 %312,00330,00312,00
314,00−4,00−1,27 %318,00324,00314,00
322,002,000,62 %320,00324,00314,00
320,004,001,25 %316,00328,00314,00
322,008,002,48 %314,00324,00308,00
320,00−6,00−1,88 %326,00326,00308,00
320,0018,005,63 %302,00322,00294,00
308,00−12,00−3,9 %320,00320,00304,00
312,00−8,00−2,56 %320,00324,00312,00
320,002,000,63 %318,00322,00316,00
316,00−10,00−3,16 %326,00334,00316,00
326,006,001,84 %320,00340,00316,00
322,00−2,00−0,62 %324,00330,00320,00
326,006,001,84 %320,00332,00318,00
322,00−8,00−2,48 %330,00338,00320,00
334,00−2,00−0,6 %336,00340,00332,00
338,002,000,59 %336,00350,00326,00
336,00−12,00−3,57 %348,00354,00332,00
344,00−20,00−5,81 %364,00368,00344,00
366,0050,0013,66 %316,00386,00312,00
320,00−6,00−1,88 %326,00334,00308,00
330,00−4,00−1,21 %334,00338,00318,00
334,004,001,2 %330,00340,00310,00
332,00−2,00−0,6 %334,00340,00320,00
338,00−12,00−3,55 %350,00350,00330,00
326,00−6,00−1,84 %332,00334,00326,00
336,004,001,19 %332,00340,00326,00
338,006,001,78 %332,00342,00324,00
330,00−10,00−3,03 %340,00348,00328,00
336,00−34,00−10,12 %370,00374,00330,00
360,00−10,00−2,78 %370,00374,00350,00
370,000,000 %370,00374,00362,00
372,00−4,00−1,08 %376,00376,00350,00
372,0018,004,84 %354,00372,00354,00
354,00−36,00−10,17 %390,00390,00352,00
380,00−2,00−0,53 %382,00394,00366,00
378,0014,003,7 %364,00394,00354,00
366,0036,009,84 %330,00366,00330,00
336,00−10,00−2,98 %346,00356,00334,00
346,00−16,00−4,62 %362,00362,00342,00
356,00−12,00−3,37 %368,00378,00350,00
364,0010,002,75 %354,00410,00354,00
356,0014,003,93 %342,00368,00334,00
342,0022,006,43 %320,00346,00308,00
322,00−6,00−1,86 %328,00334,00318,00
326,004,001,23 %322,00340,00312,00
322,002,000,62 %320,00330,00302,00
320,0022,006,88 %298,00332,00296,00
304,00−24,00−7,89 %328,00334,00302,00
330,0018,005,45 %312,00336,00302,00
310,008,002,58 %302,00310,00286,00
300,00−18,00−6 %318,00318,00294,00
320,0032,0010 %288,00322,00284,00
290,0028,009,66 %262,00294,00260,00
264,004,001,52 %260,00266,00260,00
260,00−22,00−8,46 %282,00286,00260,00
272,004,001,47 %268,00280,00266,00
272,006,002,21 %266,00274,00258,00
276,00−12,00−4,35 %288,00288,00266,00
286,0046,0016,08 %240,00290,00238,00
240,00−14,00−5,83 %254,00254,00232,00
250,0010,004 %240,00256,00238,00
240,006,002,5 %234,00240,00234,00
234,00−4,00−1,71 %238,00238,00232,00
234,00−6,00−2,56 %240,00242,00230,00
238,0018,007,56 %220,00242,00220,00
218,002,000,92 %216,00218,00212,00
210,00−4,00−1,9 %214,00216,00208,00
212,000,000 %212,00214,00204,00
208,000,000 %208,00210,00202,00
208,00−2,00−0,96 %210,00213,44208,00
212,004,001,89 %208,00222,00200,06
204,00−22,00−10,78 %226,00226,00186,00
222,004,001,8 %218,00228,00208,00
218,0014,006,42 %204,00228,00200,00
206,002,000,97 %204,00208,00188,04
204,0023,6011,57 %180,40206,00180,40
189,8619,8610,46 %170,00190,00168,00
170,0013,507,94 %156,50175,00156,50
167,80−0,20−0,12 %168,00174,00144,06
168,28−23,72−14,1 %192,00192,00162,02
190,00−14,00−7,37 %204,00204,00185,58

Liknande diskussioner

Sciatix

för 5 dagar sedan

Lovely movement

What’s triggered this

Snaga

för 3 månader sedan

Slowly and steady

Good to see some recovery lets hope for a rocket for the 2027 year

Pleasing

för 3 månader sedan

New analyst target rating set of $82

New analyst target rating set of $82

Sciatix

för 3 månader sedan

Anyone got info

What’s the crack with this fkn stock.

Sciatix

för 4 månader sedan

Beyond a joke

The management need to get their act together quickly.

Ollie130406

för 5 månader sedan

Are these ever recovering

These shares are shite bought in at 8 dollars down about 80% can’t bring myself to sell will we see a recovery ever

Sciatix

för 5 månader sedan

This is an absolute dud

Can’t believe I broke my rule on buying shite.

Damo75

för 5 månader sedan

Absolute crap

These shares are absolute crap, been at a loss for ages, wish I never bought them.

Llinxtt

för 5 månader sedan

Pretty good entry’s…

Pretty good entry’s…

Sciatix

för 5 månader sedan

What the hell

This is doing my head in.

idk30008

för 5 månader sedan

What’s happening ?

I reckon news really soon , hopefully

Damo75

för 6 månader sedan

Poor

What’s a total !@#$ show these stocks are been at a total loss for ages

Uross03

för 6 månader sedan

Im in

In at 1.42 Wish me luck (if there’s any)!

Cl1f0

för 6 månader sedan

VOLUME IS UP⬆️⬆️⬆️

Little spike and looking at the volume there will be another soon. No merger yet but I keep saying we only need to stay above $1 for another week and then we have a high percentage of merger talks thats when we see a rocket. But thats wont be the half of it any of these private companies are looking to merge. And let me tell you they are looking for a shell. Then this is a game changer. It does have to happen to be a game changer but QNCX has the best fit out of all the shells. 1. Xaira Therapeutics Backing: Launched in April 2024 with $1 billion in committed funding from major firms like ARCH Venture Partners and Foresite Capital. Why it fits: It is one of the only private biotechs to actually hit the $1 billion funding mark in a single launch. They focus on AI-driven drug discovery, a high-value sector that often attracts significant investor interest. 2. Kailera Therapeutics Backing: Has raised approximately $1 billion in total private funding as of late 2025/early 2026, including a massive $600 million Series B. Industry Focus: Obesity (GLP-1) and related metabolic diseases. Status: While they recently launched an IPO roadshow, many companies in this sector keep a "dual-track" strategy, meaning they evaluate reverse mergers with shells like QNCX simultaneously with IPO plans. 3. Eikon Therapeutics Backing: Valued at approximately $3.2 billion with significant private backing from investors like T. Rowe Price and Canada Pension Plan Investment Board. Industry Focus: Advanced microscopy and drug discovery. Recent Activity: They recently completed an IPO in early 2026, but were long considered a primary candidate for a major public market entry.

idk30008

för 6 månader sedan

Can we pls see news today !!

Honestly what was the point of clearing debt and doing a 10-1 split, if this was gonna die and if we weren’t gonna stay above $1, hopefully there’s news today or tomorrow, or consider this dead

Analyst101

för 6 månader sedan

Somethings happening behind closed doors

Somethings happening behind closed doors

cianlewis

för 6 månader sedan

RS completed

the halt is over, let's push

Cl1f0

för 6 månader sedan

RS 1-for-10 if a merger is on the cards

Ive been doing a little digging and found some previous similar scenarios all available for you to look the Internet. Because Its blown my mind how $5.5m has been paid if they expect to go bankrupt. Therefore i think there is something in the pipeline. Everything is strictly private and no info to be given. So asking AI to find me similar scenarios 1. MDGL 2. IRON 3. TECX 4.LH 5. BKNG The first 3 have similar failed drug trail and then were merged after RS as a shell and not failed company, they are all above $30.72 and MDGL is $527. I believe we have potential to be sitting pretty here. Im not selling and if it stays above $1 then we look like were have a good start. Pretty sure it has to hold for an actual handshake but this could be one of them gems. Fingers crossed. And for all you holding im with you. NFA

Denna sida kan innehålla användargenererat innehåll som Trading 212 inte ansvarar för. Skaffa alltid information på egen hand. Trading 212 är en execution only-tjänst, vilket innebär att Trading 212 inte erbjuder några investeringsråd eller någon portföljförvaltning.

Provisionsfri investering för alla

Köp och sälj IRulya Therapeutics Inc +0,25 $ (0,76 %) och över 13 000 globala aktier och ETF:er

Andra avgifter kan tillkomma. Se våra Villkor och avgifter.

Se våra villkor och avgifter här

phone

Köp aktier direkt

Välj ditt favoritföretag

Välj hur mycket du vill investera

Få dina aktier på några sekunder

Att bygga förmögenhet är en vana.
Automatisera det med ett pie.

Investera i färdiga pies eller skapa ditt eget genom att välja bland tusentals aktier och ETF

Läs mer

Läs mer

Titta på videon

Förvärva även de dyraste aktierna som Google, Amazon och Apple.

Titta på videon

Se alla handelsinstrument

Support dygnet runt

29 sekunder genomsnittlig svarstid

Börja bygga rikedom nu

Bli en av över 5 miljoner användare

Hämta appen

Öppna konto

Skaffa mobilappen

qr-code

Alla presenterade statistik är global. Antalet kunder representerar finansierade Konto.

Utmärkt

Betyg 4,6 / 5 baserat på 106 426 recensioner av

Trustpilot

Betyg 4,6 / 5 baserat på 106 426 recensioner av

Trustpilot

Inbjuden

Excellent

Using Trading 212 has been a very productive and satisfying experience for me. Because the platform is user-friendly, dependable, and simple to navigate, investing is made to be a straightforward and convenient process. I am especially grateful for the user-friendly interface, the useful investment tools, and the capability to track the performance of my portfolio in real time.

Inbjuden

I have had a fantastic experience with…

have had a fantastic experience with Trading 212. The app is modern, intuitive and incredibly easy to use, making investing feel accessible and straightforward. I particularly appreciate the clear layout, real-time updates and the ability to manage my investments conveniently in one place. The overall experience is smooth, efficient and user-friendly. Whether you are new to investing or more experienced, Trading 212 is an excellent platform that I would happily recommend to others. A brilliant app that makes investing simple!

Inbjuden

Easy to use and fantastic features

Easy to use and fantastic features

Inbjuden

Easy to operate app for everyone!

Easy to operate app for everyone!

Inbjuden

Good platform for all my investments in…

Good platform for all my investments in one place. I have ISA and recently transferred my SIPP. I have a general investment account link to 121 debit card.

Inbjuden

Awesome service and app

Awesome service and app. Well done guys :)

Inbjuden

Everything is just so easy to use

Everything is just so easy to use. You can see at a glance how everything is doing.

Inbjuden

Just a great platform user friendly 0…

Just a great platform user friendly 0 commissions with the pie attachment whats not to like choosing 212 compared to other platforms is literally a no brainer

Inbjuden

Great app easy to move money in/out…

Great app easy to move money in and out. Good to see how much interest you are making.

Inbjuden

Easy to use and intuitive

Easy to use and great dashboard to see what’s going on. Moved my stocks and shares ISA from Barclays and not looked back.

Inbjuden

Easy to use app

Easy to use app, simple processes, good rate of return and regular updates on interest earned.

Inbjuden

Quick and easy

I found that it was quick and easy to open an account; transfer funds in and out, best of all, to sit back and watch the monies increase. I would recommend Trading 212

Inbjuden

App is easy to use

The savings product i have has a good rate of return and I get daily updates. App is really easy to use

Inbjuden

212 has been a good discovery 6 years ago

212 has been a good discovery. Excellent platform for investment, secure and user friendly. Very good interest rate and good ISA

Inbjuden

Love it

Love it. Simple for a complete beginner to navigate. Perfect!

Inbjuden

The best app around

The best app around, so easy to use and navigate… makes investing easy.

Inbjuden

Easy access to transfer money.

Easy access to transfer money. Daily updates regarding interest.

Inbjuden

Great platform

Great platform, easy to navigate and buy/sell. Good statements are available.

Inbjuden

Trading 212 is very transparent

Trading 212 is very transparent, open and clear with their activities. No outrageous deductions or charges. I recommend it for everyone interested in investment

Inbjuden

Good and efficient

Good and easy to use with lots of products and investment options

Visa några av våra positiva kundrecensioner

Våra utmärkelser

Vanliga frågor och svar

Vad är aktiekursen för IRulya Therapeutics?

Det aktuella priset för IRulya Therapeutics är 33,08 $.

Vad är 52‑veckorshögsta för IRulya Therapeutics?

Högsta nivån på 52 veckor för IRulya Therapeutics är 908 $.

Vad är 52-veckorslägstanoteringen för IRulya Therapeutics?

Den lägsta nivån på 52 veckor för IRulya Therapeutics är 15,1 $.

Vad är den veckovisa prestandan för IRulya Therapeutics?

Under den senaste veckan har priset på IRulya Therapeutics ändrats med 3,28 %.

Hur ser den månatliga prestationen för IRulya Therapeutics ut?

Under den senaste månaden har priset på IRulya Therapeutics ändrats med 5,52 %.

Vad är 3-månadersprestandan för IRulya Therapeutics?

Under de senaste tre månaderna har priset på IRulya Therapeutics ändrats med 78,43 %.

Hur har 6‑månadersavkastningen för IRulya Therapeutics varit?

Under de senaste sex månaderna har priset på IRulya Therapeutics förändrats med 20,73 %.

Vad är den årliga prestandan för IRulya Therapeutics?

Under det senaste året har priset på IRulya Therapeutics förändrats med −90,91 %.